Literature DB >> 3501249

Circulating interleukin 1 and tumor necrosis factor during inflammation.

L L Moldawer1, J Gelin, T Scherstén, K G Lundholm.   

Abstract

It is proposed that interleukin 1 (IL 1) and tumor necrosis factor (TNF) alpha play central roles in the host's response to inflammation. Yet circulating concentrations have not been frequently measured in many inflammatory states. Serum levels of IL 1 and TNF were evaluated in mice with a tumor, sterile inflammation, endotoxinemia, or generalized peritonitis where an acute-phase protein response was documented. In tumor-bearing mice, no IL 1 or TNF could be detected despite marked increases in the serum concentration of the acute-phase reactant protein, amyloid P. In mice with peritonitis, induced by cecal ligation and perforation, or a turpentine-induced subcutaneous abscess, IL 1 but not TNF could be detected in the serum. Only expansion of the reticuloendothelial system with Corynebacterium parvum and subsequent challenge with endotoxin resulted in serum TNF appearance. The failure to observe IL 1 or TNF in any of the disorders could not be explained by inhibitors. Rather, the data suggest that a hepatic acute-phase protein response can occur during inflammatory states without the appearance of either IL 1 or TNF in the circulation. Circulating levels of both monokines do not appear to be a universal finding in inflammation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3501249     DOI: 10.1152/ajpregu.1987.253.6.R922

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  18 in total

1.  Cachexia and anorexia.

Authors:  G Mantovani
Journal:  Support Care Cancer       Date:  2000-11       Impact factor: 3.603

Review 2.  Managing cancer-related anorexia/cachexia.

Authors:  G Mantovani; A Macciò; E Massa; C Madeddu
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Comparative effects of tumour necrosis factor-alpha (cachectin), interleukin-1-beta and tumour growth on amino acid metabolism in the rat in vivo. Absorption and tissue uptake of alpha-amino[1-14C]isobutyrate.

Authors:  J M Argilés; F J López-Soriano; D Wiggins; D H Williamson
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

4.  Hydrogen sulfide inhibits NLRP3 inflammasome activation and reduces cytokine production both in vitro and in a mouse model of inflammation.

Authors:  Mariela Castelblanco; Jérôme Lugrin; Driss Ehirchiou; Sonia Nasi; Isao Ishii; Alexander So; Fabio Martinon; Nathalie Busso
Journal:  J Biol Chem       Date:  2017-12-26       Impact factor: 5.157

Review 5.  Cytokines as mediators in the regulation of the hypothalamic-pituitary-adrenocortical function.

Authors:  J Fukata; H Imura; K Nakao
Journal:  J Endocrinol Invest       Date:  1994-02       Impact factor: 4.256

6.  Lipopolysaccharide-tumor necrosis factor-glucocorticoid interactions during cecal ligation and puncture-induced sepsis in mature versus senescent mice.

Authors:  S R Hyde; R E McCallum
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

7.  Changes in the productivity of cytokines and active-oxygen in peripheral blood cells following surgery.

Authors:  Y Abe; M Miyake; A Horiuchi; K Kumori; S Kimura
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

8.  Interaction of transforming growth factor-beta-1 with alpha-2-macroglobulin from normal and inflamed equine joints.

Authors:  N Coté; D R Trout; M A Hayes
Journal:  Can J Vet Res       Date:  1998-10       Impact factor: 1.310

9.  Effects of murine recombinant interleukin 1 on synovial joints in mice: measurement of patellar cartilage metabolism and joint inflammation.

Authors:  A A van de Loo; W B van den Berg
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

10.  Endotoxin tolerance: independent regulation of interleukin-1 and tumor necrosis factor expression.

Authors:  S H Zuckerman; G F Evans; L D Butler
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.